cbdMD (YCBD) EPS (Basic) Growth (1y) (2017 - 2025)
cbdMD (YCBD) EPS (Basic) Growth (1y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 65.56% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 5.87% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -389.31% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -11.93% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 105.98% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2,385.12% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -15.37% |
| 10 | cbdMD | 438,678.80 | -2.95 Mn | 3.00 Mn | 97.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 97.92% |
| Sep 30, 2025 | 92.11% |
| Jun 30, 2025 | 82.35% |
| Mar 31, 2025 | 82.44% |
| Dec 31, 2024 | 67.90% |
| Sep 30, 2024 | 96.79% |
| Jun 30, 2024 | 87.07% |
| Mar 31, 2024 | 22.01% |
| Dec 31, 2023 | 81.75% |
| Sep 30, 2023 | 29.12% |
| Jun 30, 2023 | 95.30% |
| Mar 31, 2023 | 59.77% |
| Dec 31, 2022 | 76.45% |
| Sep 30, 2022 | -229.63% |
| Jun 30, 2022 | -3,291.57% |
| Mar 31, 2022 | 60.75% |
| Dec 31, 2021 | -91.41% |
| Sep 30, 2021 | 44.91% |
| Jun 30, 2021 | 109.78% |
| Mar 31, 2021 | -160.36% |